ConductScience.org, home

Gene · 8321

NIH grants1,683

NIH grants whose papers are about the gene, through NIH's grant-paper links.

561 to 580 of 1,683

Download this page as JSON
GrantTitleFZD1 papersNewest fiscal year
R21CA256428Improving response to immunotherapy by genistein and antiestrogens12021
R21ES030334Alternative splicing in arsenical skin carcinogenesis12021
R21EY031092Investigating the role of NKX6-1 in secondary lens fiber cell differentiation12021
R21NS119954Oligodendroglial Intrinsic Ring Finger Protein family members are injury specific, but not developmental, regulators of oligodendrocyte maturation12021
R35CA197450DISE - a natural cancer surveillance mechanism - a new road to cancer therapy12021
R35GM119574Deciphering Wnt-Ror signaling in cytoskeletal regulation and tissue shape control12021
R37AR047709WNT Signals in Skin and Hair Development and Growth12021
T32DK007540Training for Multidisciplinary Research in Nephrology12021
T32ES007272Training in Environmental Pathology12021
T32GM007280Mount Sinai Medical Scientist Training Program12021
T32GM007445Biochemistry, Cellular and Molecular Biology Program12021
T32GM007491Training Program in Cellular and Molecular Biology and Genetics12021
T32GM008208Medical Scientist Training Program12021
T32GM065103Interdisciplinary Predoctoral Training in Molecular Biophysics12021
T32GM099608Predoctoral Training in Pharmacological Sciences12021
T32HL103104T32 Training Program for Institutions That Promote Diversity from Morehouse School of Medicine12021
T32NS043124Multidisciplinary Training in Brain Disorders and Development12021
U01CA200469Development of in vitro diagnostic multivariate index assay using liquid-based cervical cytology specimen and/or serum/plasma biomarkers for the detection of early stage or low-volume ovarian cancer12021
U01CA214125MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS12021
U01CA214292Engineered Invasive Human Breast Tumors with Integrated Capillaries and Lymphatics12021

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/8321/grants?page=29